Posttranslational, Reversible O-Glycosylation Is Stimulated by High Glucose and Mediates Plasminogen Activator Inhibitor-1 Gene Expression and Sp1 Transcriptional Activity in Glomerular Mesangial Cells
- 1 January 2006
- journal article
- research article
- Published by The Endocrine Society in Endocrinology
- Vol. 147 (1) , 222-231
- https://doi.org/10.1210/en.2005-0523
Abstract
Metabolic flux through the hexosamine biosynthetic pathway (HBP) is increased in the presence of high glucose (HG) and potentially stimulates the expression of genes associated with the development of diabetic nephropathy. A number of synthetic processes are coupled to the HBP, including enzymatic intracellular O-glycosylation (O-GlcNAcylation), the addition of single O-linked N-acetylglucosamine monosaccharides to serine or threonine residues. Despite much data linking flow through the HBP and gene expression, the exact contribution of O-GlcNAcylation to HG-stimulated gene expression remains unclear. In glomerular mesangial cells, HG- stimulated plasminogen activator inhibitor-1 (PAI-1) gene expression requires the HBP and the transcription factor, Sp1. In this study, the specific role of O-GlcNAcylation in HG- induced PAI-1 expression was tested by limiting this modification with a dominant-negative O-linked N-acetylglucosamine transferase, by overexpression of neutral beta-N-acetylglucosaminidase, and by knockdown of O-linked beta-N-acetylglucosamine transferase expression by RNA interference. Decreasing O-GlcNAcylation by these means inhibited the ability of HG to increase endogenous PAI-1 mRNA and protein levels, the activity of a PAI-1 promoter-luciferase reporter gene, and Sp1 transcriptional activation. Conversely, treatment with the beta-N-acetylglucosaminidase inhibitor, O-(2-acetamido-2-deoxy-D-glucopyranosylidene) amino-N-phenylcarbamate, in the presence of normal glucose increased Sp1 O-GlcNAcylation and PAI-1 mRNA and protein levels. These findings demonstrate for the first time that among the pathways served by the HBP, O-GlcNAcylation, is obligatory for HG- induced PAI-1 gene expression and Sp1 transcriptional activation in mesangial cells.This publication has 51 references indexed in Scilit:
- O-GlcNAc a sensor of cellular state: the role of nucleocytoplasmic glycosylation in modulating cellular function in response to nutrition and stressPublished by Elsevier ,2004
- P38 mitogen-activated protein kinase mediates hexosamine-induced TGFβ1 mRNA expression in human mesangial cellsDiabetologia, 2003
- Molecular Understanding of Hyperglycemia's Adverse Effects for Diabetic ComplicationsJAMA, 2002
- Hexosamines as mediators of nutrient sensing and regulation in diabetesJournal of Diabetes and its Complications, 2002
- Biochemistry and molecular cell biology of diabetic complicationsNature, 2001
- Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt siteJournal of Clinical Investigation, 2001
- Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylationProceedings of the National Academy of Sciences, 2000
- Decreased UDP-GlcNAc levels abrogate proliferation control in EMeg32-deficient cellsThe EMBO Journal, 2000
- High glucose-induced transforming growth factor beta1 production is mediated by the hexosamine pathway in porcine glomerular mesangial cells.Journal of Clinical Investigation, 1998
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1993